trending Market Intelligence /marketintelligence/en/news-insights/trending/8R8bSxjsDjC3rjj9F66K4g2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us
In This List

Rigel Pharmaceuticals prices common stock offering

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help


Rigel Pharmaceuticals prices common stock offering

Rigel Pharmaceuticals Inc. priced an underwritten public offering of 18,100,000 common shares at $3.35 apiece to raise about $60.6 million in gross proceeds.

The company granted underwriters a 30-day option to buy up to an additional 2,715,000 common shares at the offering price.

The offering is expected to close Oct. 10, subject to customary closing conditions.

Jefferies LLC and BMO Capital Markets Corp. are acting as joint book-running managers for the offering, with H.C. Wainwright & Co. LLC as lead manager.